Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析

◆英語タイトル:Dawnrays Pharmaceutical (Holdings) Ltd (2348) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14991
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥32,100見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥64,200見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥96,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude and cefotaxime acid, among others. It also provides cephalosporin antibiotic intermediates, bulk medicines and powder for injections for therapeutic areas such as anti-allergic, digestive system, cardiovascular system and urinary system and endocrine system, among others. Dawnrays’s research and development activities are concentrated on generic drugs of system specific medicines. The company markets its products in Hong Kong and abroad. Dawnrays is headquartered in Hong Kong.

Dawnrays Pharmaceutical (Holdings) Ltd Key Recent Developments

Aug 23,2018: Dawnrays Pharmaceutical announced its interim results for the six months ended 30 June 2018

This comprehensive SWOT profile of Dawnrays Pharmaceutical (Holdings) Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Dawnrays Pharmaceutical (Holdings) Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Dawnrays Pharmaceutical (Holdings) Ltd – Key Information
Dawnrays Pharmaceutical (Holdings) Ltd – Overview
Dawnrays Pharmaceutical (Holdings) Ltd – Key Employees
Dawnrays Pharmaceutical (Holdings) Ltd – Key Employee Biographies
Dawnrays Pharmaceutical (Holdings) Ltd – Key Operational Heads
Dawnrays Pharmaceutical (Holdings) Ltd – Major Products and Services
Dawnrays Pharmaceutical (Holdings) Ltd – History
Dawnrays Pharmaceutical (Holdings) Ltd – Company Statement
Dawnrays Pharmaceutical (Holdings) Ltd – Locations And Subsidiaries
Dawnrays Pharmaceutical (Holdings) Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Dawnrays Pharmaceutical (Holdings) Ltd – Business Description
Dawnrays Pharmaceutical (Holdings) Ltd – Corporate Strategy
Dawnrays Pharmaceutical (Holdings) Ltd – SWOT Analysis
SWOT Analysis – Overview
Dawnrays Pharmaceutical (Holdings) Ltd – Strengths
Dawnrays Pharmaceutical (Holdings) Ltd – Weaknesses
Dawnrays Pharmaceutical (Holdings) Ltd – Opportunities
Dawnrays Pharmaceutical (Holdings) Ltd – Threats
Dawnrays Pharmaceutical (Holdings) Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Dawnrays Pharmaceutical (Holdings) Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Dawnrays Pharmaceutical (Holdings) Ltd, Key Information
Dawnrays Pharmaceutical (Holdings) Ltd, Key Ratios
Dawnrays Pharmaceutical (Holdings) Ltd, Share Data
Dawnrays Pharmaceutical (Holdings) Ltd, Major Products and Services
Dawnrays Pharmaceutical (Holdings) Ltd, History
Dawnrays Pharmaceutical (Holdings) Ltd, Key Employees
Dawnrays Pharmaceutical (Holdings) Ltd, Key Employee Biographies
Dawnrays Pharmaceutical (Holdings) Ltd, Key Operational Heads
Dawnrays Pharmaceutical (Holdings) Ltd, Other Locations
Dawnrays Pharmaceutical (Holdings) Ltd, Subsidiaries
Dawnrays Pharmaceutical (Holdings) Ltd, Key Manufacturing facilities
Dawnrays Pharmaceutical (Holdings) Ltd, Key Competitors
Dawnrays Pharmaceutical (Holdings) Ltd, SWOT Analysis
Dawnrays Pharmaceutical (Holdings) Ltd, Ratios based on current share price
Dawnrays Pharmaceutical (Holdings) Ltd, Annual Ratios
Dawnrays Pharmaceutical (Holdings) Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Dawnrays Pharmaceutical (Holdings) Ltd, Performance Chart
Dawnrays Pharmaceutical (Holdings) Ltd, Ratio Charts

★海外企業調査レポート[Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Welltower Inc:企業のM&A・事業提携・投資動向
    Welltower Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Welltower Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Global Partners LP (GLP):石油・ガス:M&Aディール及び事業提携情報
    Summary Global Partners LP (Global Partners) is a midstream logistics and marketing master limited partnership. It carries out purchasing, selling and logistics of transporting domestic and Canadian crude oil and other products by rail across its virtual pipeline from the mid-continent region of the …
  • Kentucky Power Co:企業の発電所・SWOT分析2018
    Kentucky Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Macintosh Retail Group NV:企業概要・SWOT・財務分析
    Summary Canadean's "Macintosh Retail Group NV : Retailing - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, …
  • Baxter International Inc.:企業のM&A・事業提携・投資動向
    Baxter International Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Baxter International Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Quest Diagnostics Inc (DGX):医療機器:M&Aディール及び事業提携情報
    Summary Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esot …
  • SSP Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SSP Limited Mergers and Acquisi …
  • Ted Baker plcの企業概要及び財務/SWOT分析
    Ted Baker plc Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Ted Baker plc annual and quarterly forecasts made by stock market experts. The report also enables direct compar …
  • Wilson Therapeutics AB (WTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Wilson Therapeutics AB (Wilson Therapeutics), a subsidiary of Alexion Pharma Nordics AB, is a biopharmaceutical company that develops novel therapies for patients with rare copper-mediated disorders. The company’s lead product includes WTX101 is a copper-protein-binding agent, which is used …
  • Korea Line Corporation (005880):企業財務及び戦略的SWOT分析
    Summary Korea Line Corporation (KLC) is a shipping company that offers dedicated carrier services and tramper carrier services. The company transports liquid natural gas through vessels and provides tramper carrier service related to dry bulk products. It also transports iron ore, coal, grain, steel …
  • John B. Sanfilippo and Son, Inc.:企業の戦略・SWOT・財務分析
    SummaryJohn B. Sanfilippo and Son, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • ICSA (India) Ltd (ICSA):企業財務及び戦略的SWOT分析
    Summary ICSA (India) Ltd (ICSA) is a technology company that offers customized embedded solutions and services. The company provides data acquisition system using communication media such as GSM, GPRS, CDMA, PLCC, Optical Fiber and RF. ICSA’s offers solutions which include power applications, pipeli …
  • Capsule Technologie S.A.:企業の戦略的SWOT分析
    Capsule Technologie S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Emblaze, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Emblaze, Ltd. Mergers and Acqui …
  • WideMed Technologies LTD:医療機器:M&Aディール及び事業提携情報
    Summary WideMed Technologies LTD (WideMed) is a medical device company that develops and manufactures information systems for monitoring, diagnosis and analysis of sleep disorders. The company’s products include Morpheus Modules, Morpheus Hx and Morpheus Ox. Its Morpheus modules are automatic scorin …
  • Progenitor Cell Therapy LLC-製薬・医療分野:企業M&A・提携分析
    Summary Progenitor Cell Therapy LLC (PCT), a subsidiary of Caladrius Biosciences Inc is an external development and manufacturing company that offers cell therapy products. The company offers services that include cell and tissue processing; storage, distribution and delivery; consulting and regulat …
  • GP JOULE GmbH:企業のM&A・提携動向(発電分野)
    Summary GP JOULE GmbH (GP JOULE) is an alternative energy company that provides natural resource conservation solutions. The company’s products include green house systems, solar carports and movers. Its services include engineering, planning, procurement and construction; and operation and maintena …
  • U.S. Department of Veterans Affairs:企業のM&A・提携動向(発電分野)
    Summary U.S. Department of Veterans Affairs (DVA) is a healthcare organization that offers benefit management and veteran services. The organization offers general benefits information, disability compensation, pension, GI bill, vocational rehabilitation and employment, vet success, educational coun …
  • Japan U-Pica Company, Ltd. (7891):企業の財務及び戦略的SWOT分析
    Summary Japan U-Pica Company, Ltd. (U-Pica) is a chemical company that manufactures and sells unsaturated polester resins, epoxy acrylate resins, coating resins and methacrylic ester monomers. Its products include BIOMUP biomass polyester resin, CFRP for CBZ, powder coatings BIOMUP, HAA curable powd …
  • Endotronix Inc-医療機器分野:企業M&A・提携分析
    Summary Endotronix Inc (Endotronix) is a medical device company that provides digital health solutions. The company offers wireless health monitoring solutions to congestive heart failure patients. It develops endotronix care management solution to communicate pressures that accurately measure cardi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆